Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FHCB4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,287
Award facts
- Contract value 100% obligated
- $13,287.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,287 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply solutions to support Department of Defense healthcare operations globally. This particular delivery order carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group Inc. was selected as one of multiple regional prime vendor contractors under the PPV-G GEN V program through its single-award IDC designated SPE2DR, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The IDC authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a full range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. As the sole prime contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group demonstrates established performance capabilities across diverse pharmaceutical requirements essential to federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FHCB4?
SPE2DR26FHCB4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FHCB4 worth?
The government has obligated $13,287 on SPE2DR26FHCB4.
Is contract SPE2DR26FHCB4 an order under another contract?
Yes. SPE2DR26FHCB4 is a delivery order under SPE2DR25D9205, an indefinite delivery contract.
Was contract SPE2DR26FHCB4 competed?
The extent of competition for SPE2DR26FHCB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award